FDA Inspection
LEESAR, INCLEESAR, INC – FDA Inspection, Jul 12, 2017
Record Details
This FDA Inspection record concerns LEESAR, INC, with an inspection on July 12, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Ian F. Deveau (FDA Associated Person)
- Jennifer Lalama (FDA Associated Person)
- June P. Page (FDA Associated Person)
- Justine Tomasso (Issuing Officer)
View Company Profile
ID · 1c0f6637-7e3e-41a6-ad64-e474ec2bb395
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1017863
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.42(c)(10)(vi)Equipment to control conditions
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.160(a)Lab controls established, including changes
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LEESAR, INC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2026 | Not classified | Florida District Office | |
| July 18, 2025 | NAI | Florida District Office | Postmarket Assurance: Medical Devices |
| May 9, 2025 | VAI | Florida District Office | Drug Quality Assurance |
| October 29, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 8, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for LEESAR, INC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.